5 results match your criteria: "3 rd Medical Clinic[Affiliation]"
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.
J Hepatol
November 2024
Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria. Electronic address:
Background & Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of advanced chronic liver disease (ACLD). Portal hypertension drives hepatic decompensation and is best diagnosed by hepatic venous pressure gradient (HVPG) measurement. Here, we investigate the prognostic value of HVPG in MASLD-related compensated ACLD (MASLD-cACLD).
View Article and Find Full Text PDFRadiotherapy and newly approved cancer drugs - A quantitative analysis of registered protocols for drugs approved for the treatment of solid tumors.
Radiother Oncol
March 2022
Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Germany. Electronic address:
Background/purpose: To evaluate the usage of RT in trial protocols for anti-cancer drugs approved by the US Food and Drug Administration (FDA).
Methods: Drugs which had been granted an FDA approval between 2010 and 2017 for the treatment of solid tumors in adults were identified. Use of RT in relation to each drug's approval date was reviewed on ClinicalTrials.
Validation and Performance of Chronic Liver Disease Questionnaire (CLDQ-RO) in the Romanian Population.
J Gastrointestin Liver Dis
June 2021
Prof. Dr. O. Fodor Regional Institute of Gastroenterology and Hepatology, Hepatology Department, Cluj-Napoca, Romania; Liver Research Club, Cluj- Napoca, Romania; Iuliu Hatieganu University of Medicine and Pharmacy, 3 rd Medical Clinic, Hepatology Department, Cluj-Napoca, Romania.
Background And Aims: Health-related quality of life is an essential part of managing chronically ill patients, including patients with chronic liver disease. Various methods are used to try to assess the quality of life ranging from generic to disease-specific questionnaires. Some of the results may reveal a novel connection to the disease's evolution, which is observed directly by the patient.
View Article and Find Full Text PDFThe Use of Handheld Ultrasound Devices - An EFSUMB Position Paper.
Ultraschall Med
February 2019
Department of Internal Medicine 2, Caritas-Krankenhaus, Bad Mergentheim, Sino-German Research Center of Ultrasound in Medicine, Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
The Use of Handheld Ultrasound Devices - An EFSUMB Position Paper.
Ultraschall Med
February 2019
Department of Internal Medicine 2, Caritas-Krankenhaus, Bad Mergentheim, Sino-German Research Center of Ultrasound in Medicine, Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
The miniaturization of ultrasound equipment in the form of tablet- or smartphone-sized ultrasound equipment is a result of the rapid evolution of technology and handheld ultrasound devices (HHUSD). This position paper of the European Federation of Societies in Ultrasound and Medicine (EFSUMB) assesses the current status of HHUSD in abdominal ultrasound, pediatric ultrasound, targeted echocardiography and heart ultrasound, and we will report position comments on the most common clinical applications. Also included is a SWOT (Strength - Weaknesses - Opportunities - Threats) analysis, the use for handheld devices for medical students, educational & training aspects, documentation, storage and safety considerations.
View Article and Find Full Text PDF